Podcasts

Episode 57 | CNS Progression in Lung Cancer - A Practical Conversation on Best Practices

In this episode, A/Prof Tim Clay, Dr Keryn Davidson and A/Prof Fiona Hegi-Johnson discuss the multidisciplinary management of CNS metastases in the context of thoracic cancers.

Episode Summary

In this episode of Conversations in Lung Cancer Research, A/Prof Tim Clay discusses the multidisciplinary management of CNS metastases in the context of thoracic cancers. Joined by Dr Keryn Davidson, a consultant neurosurgeon, and A/Prof Fiona Hegi Johnson, a radiation oncologist, the discussion focuses on the nuances of treating patients with non-small cell lung cancer presenting with brain metastases. Key topics include the role of neurosurgery, decision-making for radiation therapy, evolving approaches for oncogene-driven cancer patients, management of radiation necrosis, and the complexities of treating small cell lung cancer and leptomeningeal disease.  

Show Guests

  • A/Prof Tim Clay, Medical Oncologist, St John of God Subiaco Hospital
  • A/Prof Fiona Hegi Johnson, Radiation Oncologist, Peter McCallum Cancer Center and senior research fellow at the University of Melbourne
  • Dr Keryn Davidson, Neurosurgeon, North Shore Private and Royal North Shore Hospitals

Sponsor

This episode is sponsored by Pfizer.

Show notes

Lung cancer podcast- brain metastases and central nervous system (CNS) progression. with Tim Clay

Play Episode 57 | CNS Progression in Lung Cancer - A Practical Conversation on Best Practices

More Podcasts

Host A/Prof Steven Kao is joined by A/Prof Venessa Chin and Dr Ben Kong,
Host A/Prof Mel Moore interviews Prof Zarnie Lwin OAM, University of Queensland; Medical Oncologist at Royal Brisbane and Women’s Hospital and The Prince Charles Hospital.
A/Prof Gavin Wright sits down with a multidisciplinary panel of experts to tackle the critical and complex issue of smoking-related stigma in lung cancer.
Host A/Prof Mel Moore interviews Dr Jazmin Eckhaus, a practising surgeon in the subspecialty of thoracic surgery.
Host A/Prof Adnan Nagrial leads a panel discussing the clinical implications of the broad PBS listing of ipilimumab and nivolumab in Australia.
Host A/Prof Deme Karikios leads a panel discussion focusing on the recent, groundbreaking broad PBS listing of certain immunotherapy agents in Australia.